Comparison of the Application of Lidocaine With Intraperitoneal Bupivacaine in Cesarian Operations Wound Infiltration
Postoperative Pain, Cesarean Section
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria:
- Pregnant women
- 18-50 years
ASA I-II,
-≥34th gestational week
- Exclusion Criteria:
- Patients with neuraxial anesthesia contraindications
- Patients allergic to drugs to be used in the study
- BMI> 35 kg / m2
- Diabetes, preeclampsia, cardiovascular disease, chronic pain and neuropathic pain
- Patients who have been given opioids in operation due to intraoperative pain
- Patients with unsuccessful spinal anesthesia who underwent general anesthesia
- Patients with excessive bleeding during the operation, uterine atony, placement of the drain in the area to be infiltrated
- Patients who do not want spinal anesthesia,
- Cannot understand VAS
- History of drug addiction and psychiatric illness
Sites / Locations
- Ataturk UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
IPLA:intraperitoneal local anesthetic
LWI:Surgical wound infiltration
C: CONTROL GROUP
intraperitoneal local anesthetic:after the birth of the newborn and placenta, the uterus is closed and the blood accumulated in the pelvis is carefully wiped with surgical towels, after hemostasis is fully achieved, a total of 20 ml solution containing 10 cc of 0.5% bupivacaine +10 cc 2% lidocaine and 2 injectors containing 20ml saline and the 20ml solution were given to the surgeon. The 20 ml solution containing bupivacaine and lidocaine was injected into the uterine peritoneal region by spraying 5 mL to each quadrant of the uterus before closing the parietal peritoneum or fascia. The parietal peritoneal layer was sutured or left open at the surgeon's preference. At the end of the operation, 20 ml of saline solution was applied subcutaneously in the form of LWI instead of the incision before the skin was closed.
Surgical wound infiltration:a solution containing 20 ml of saline was added to all four quadrants of the uterus in 5 ml volume and 20 ml solution containing lidocaine and bupivacaine were subcutaneously in the form of LWI before the skin was closed.
one of the two sterile injectors containing 20 ml of saline was applied to the uterine peritoneal region and the other was applied to the incision area as a local subcutaneous wound infiltration.